Dr. Novack’s contributions to the Journal of Ocular Pharmacology and Therapeutics highlighted

In a recent article in the Journal of Ocular Pharmacology and Therapeutics (JOPT), the present editor, Uday Kompella PhD of the University of Colorado, joined with past editors Craig Crosson Ph.D., David E. Potter, Ph.D., and W. Dan Stamer, Ph.D. to mark the 40th anniversary of the journal. In the article, they note the Dr. Novack for over 10 years of service in keeping the JOPT audience up to date on the status of novel ocular therapeutics and government regulations that affect their development. In addition, Drs.
Stamer and Novack wrote about the importance of ‘‘Therapeutics’’ in the title and mission of JOPT, hearkening back to Dr. Chiou’s name change in 1995.

Stamer WD, Crosson CE, Potter DE, Kompella UB. The JOPT Story: 40 Years of Growth and Focus. J Ocul Pharmacol Ther 2024;40(3):155-6.

About Dr. Novack

Dr. Gary Novack is a board-certified clinical pharmacologist and President of PharmaLogic Development with more than 40 years of experience in ophthalmic drug development, clinical research, and FDA regulatory strategy.

He has consulted for over 100 pharmaceutical and medical device companies and authored more than 400 scientific publications.

Contact Dr. Novack
Contact Dr. Novack